Your browser doesn't support javascript.
loading
Specific RITA Modification Produces Hyperselective Cytotoxicity While Maintaining In Vivo Antitumor Efficacy.
Peyser, Brian D; Hermone, Ann; Salamoun, Joseph M; Burnett, James C; Hollingshead, Melinda G; McGrath, Connor F; Gussio, Rick; Wipf, Peter.
Afiliación
  • Peyser BD; Computational Drug Development Group, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland. brian.peyser@nih.gov.
  • Hermone A; Computational Drug Development Group, Developmental Therapeutics Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland.
  • Salamoun JM; Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Burnett JC; Computational Drug Development Group, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland.
  • Hollingshead MG; Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • McGrath CF; Biological Testing Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland.
  • Gussio R; Computational Drug Development Group, Developmental Therapeutics Program, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland.
  • Wipf P; Computational Drug Development Group, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland.
Mol Cancer Ther ; 18(10): 1765-1774, 2019 10.
Article en En | MEDLINE | ID: mdl-31341033

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Furanos / Antineoplásicos Límite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2019 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Furanos / Antineoplásicos Límite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2019 Tipo del documento: Article